Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

Trial ID or NCT#

NCT00373347

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to identify blood markers that have the ability to diagnose liver cancer with improved accuracy, so that it can be used alone or in conjunction with alpha-feto protein (AFP)

Official Title

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Samuel So, MD
Samuel So, MD
Surgical oncologist, Liver surgeon, General surgeon
Lui Hac Minh Professor in the School of Medicine

Contact us to find out if this trial is right for you.

Contact

Mei-Sze Chua
650-724-3525

View on ClinicalTrials.gov